A detailed history of Exane Derivatives transactions in Centrus Energy Corp stock. As of the latest transaction made, Exane Derivatives holds 38,214 shares of LEU stock, worth $2.87 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
38,214
Previous 19,285 98.15%
Holding current value
$2.87 Million
Previous $649,000 45.61%
% of portfolio
0.6%
Previous 0.2%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

BUY
$18.63 - $35.99 $352,647 - $681,254
18,929 Added 98.15%
38,214 $945,000
Q1 2022

Apr 22, 2022

SELL
$31.72 - $52.71 $429,520 - $713,746
-13,541 Reduced 41.25%
19,285 $649,000
Q4 2021

Jan 28, 2022

BUY
$37.45 - $85.59 $886,141 - $2.03 Million
23,662 Added 258.21%
32,826 $1.64 Million
Q3 2021

Oct 26, 2021

BUY
$22.12 - $39.55 $4,800 - $8,582
217 Added 2.43%
9,164 $354,000
Q2 2021

Jul 28, 2021

BUY
$20.65 - $28.23 $10,903 - $14,905
528 Added 6.27%
8,947 $227,000
Q1 2021

Apr 30, 2021

SELL
$19.65 - $27.88 $19,217 - $27,266
-978 Reduced 10.41%
8,419 $199,000
Q4 2020

Jan 27, 2021

BUY
$8.63 - $27.91 $81,096 - $262,270
9,397 New
9,397 $217,000

Others Institutions Holding LEU

About CENTRUS ENERGY CORP


  • Ticker LEU
  • Exchange NYSE
  • Sector Energy
  • Industry Uranium
  • Shares Outstandng 13,769,400
  • Market Cap $1.03B
  • Description
  • Centrus Energy Corp. supplies nuclear fuel and services for the nuclear power industry in the United States, Japan, Belgium, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) component of LEU; SWU and natural uranium components of ...
More about LEU
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.